Age, Biography and Wiki
Yuan Chang was born on 17 November, 1959 in Taipei, Taiwan, is an American virologist and pathologist. Discover Yuan Chang's Biography, Age, Height, Physical Stats, Dating/Affairs, Family and career updates. Learn How rich is he in this year and how he spends money? Also learn how he earned most of networth at the age of 64 years old?
Popular As |
N/A |
Occupation |
N/A |
Age |
64 years old |
Zodiac Sign |
Scorpio |
Born |
17 November, 1959 |
Birthday |
17 November |
Birthplace |
Taipei, Taiwan |
Nationality |
United States
|
We recommend you to check the complete list of Famous People born on 17 November.
He is a member of famous with the age 64 years old group.
Yuan Chang Height, Weight & Measurements
At 64 years old, Yuan Chang height not available right now. We will update Yuan Chang's Height, weight, Body Measurements, Eye Color, Hair Color, Shoe & Dress size soon as possible.
Physical Status |
Height |
Not Available |
Weight |
Not Available |
Body Measurements |
Not Available |
Eye Color |
Not Available |
Hair Color |
Not Available |
Who Is Yuan Chang's Wife?
His wife is Patrick S. Moore
Family |
Parents |
Not Available |
Wife |
Patrick S. Moore |
Sibling |
Not Available |
Children |
Not Available |
Yuan Chang Net Worth
His net worth has been growing significantly in 2023-2024. So, how much is Yuan Chang worth at the age of 64 years old? Yuan Chang’s income source is mostly from being a successful . He is from United States. We have estimated Yuan Chang's net worth, money, salary, income, and assets.
Net Worth in 2024 |
$1 Million - $5 Million |
Salary in 2024 |
Under Review |
Net Worth in 2023 |
Pending |
Salary in 2023 |
Under Review |
House |
Not Available |
Cars |
Not Available |
Source of Income |
|
Yuan Chang Social Network
Timeline
Yuan Chang (born 17 November 1959) is a Taiwanese-born American virologist and pathologist who co-discovered together with her husband, Patrick S. Moore, the Kaposi's sarcoma-associated herpesvirus (KSHV) and Merkel cell polyomavirus, two of the seven known human oncoviruses.
Chang was born in Taiwan and moved to the United States as a young child.
She was raised in Salt Lake City, Utah and received an MD from the University of Utah College of Medicine.
Chang trained in neuropathology at Stanford University under the noted clinical neuropathologist, Dikran Horoupian, publishing studies on eosinophilia-myalgia syndrome and progressive multifocal leukoencephalopathy.
During this period she contributed to studies led by her friend, Julie Parsonnet, showing that Helicobacter pylori is a cause for gastric cancer.
Chang moved to Columbia University to pursue her first academic appointment as a clinician-scientist.
Although initially interested in using representational difference analysis to study the genetic origins of brain tumors, she applied this technique to Kaposi's sarcoma resulting in the discovery of this new human tumor virus.
In 1994, she co-discovered KSHV, also called human herpesvirus-8 (HHV-8), working with her husband Patrick S. Moore at Columbia University.
Chang, Moore and collaborators subsequently showed that this virus was the etiologic agent of Kaposi's sarcoma and primary effusion lymphoma, while others showed it to be the cause of some forms of multicentric Castleman's disease.
From two small DNA fragments representing less than 1% of the viral genome, she cloned the entire KSHV 165 kbase genome and fully sequenced the virus genome within two years after its initial discovery.
This led to blood tests to detect infection for this virus, discovery of viral proteins likely to cause cancer and elucidation of the role of immune evasion in carcinogenesis caused by virus infection.
Dr. Chang is now the American Cancer Society Professor in the Department of Pathology at the University of Pittsburgh.
She has received a number of awards for her work, including the Meyenburg Foundation Award for Cancer Research, the Robert Koch Prize, The Sloan-Kettering Paul Marks Prize for Cancer Research, the New York City Mayor's Award for Excellence in Science & Technology, the General Motors Charles S. Mott Prize in Cancer Research, the Carnegie Science Award and an American Cancer Society Research Professorship.